IPP: International Process Plants buys Novartis UK's pharmaceutical manufacturing site

International Process Plants (IPP) announced its subsidiary Humber Industrials Ltd. has reached an agreement to purchase Novartis UK's 170-acre active pharmaceutical ingredient (API) manufacturing plant site and assets in Grimsby, UK. "We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capac...